Cargando…
DNA methylation profile in patients with indolent systemic mastocytosis
BACKGROUND: Mastocytosis is a clinically heterogeneous, usually acquired disease of the mast cells with a survival time that depends on the onset of the disease and ranges from skin‐limited to systemic disease, including indolent and more aggressive variants. The crucial element in pathogenesis is t...
Autores principales: | Górska, Aleksandra, Jabłońska, Ewa, Reszka, Edyta, Niedoszytko, Marek, Lange, Magdalena, Gruchała‐Niedoszytko, Marta, Jarczak, Justyna, Strapagiel, Dominik, Górska‐Ponikowska, Magdalena, Bastian, Paulina, Pelikant‐Małecka, Iwona, Kalinowski, Leszek, Nedoszytko, Bogusław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561632/ https://www.ncbi.nlm.nih.gov/pubmed/34754417 http://dx.doi.org/10.1002/clt2.12074 |
Ejemplares similares
-
Genome-Wide DNA Methylation and Gene Expression in Patients with Indolent Systemic Mastocytosis
por: Górska, Aleksandra, et al.
Publicado: (2023) -
Modulation of dermal equivalent of hypothalamus-pituitary-adrenal axis in mastocytosis
por: Antoniewicz, Jakub, et al.
Publicado: (2021) -
Results from a Genome-Wide Association Study (GWAS) in Mastocytosis Reveal New Gene Polymorphisms Associated with WHO Subgroups
por: Nedoszytko, Bogusław, et al.
Publicado: (2020) -
Epigenetic Changes in Neoplastic Mast Cells and Potential Impact in Mastocytosis
por: Reszka, Edyta, et al.
Publicado: (2021) -
Association of mastocytosis with interleukin 31 gene polymorphism
por: Nedoszytko, Boguslaw, et al.
Publicado: (2015)